Current Regulatory Status in the UK Retatrutide is not approved by the MHRA or EMA and is unavailable as a licensed medicine in the UK
Because of this, you may get good weight loss results
Retatrutide SLU-PP-332 is a novel small molecule and a potent pan-agonist of the estrogen-related receptors (ERR, ERR, and ERR), which are key regulators of energy metabolism and mitochondrial function
Nutrition and healthy eating
Originally developed to help treat type 2 diabetes, GLP-1 drugs have proven effective at promoting weight loss , at least for as long as the medications remain in use
What is fascinating is that their effects are not limited to alcohol: preclinical and correlational data indicate possible benefits in decreasing use of nicotine and opioids, which makes sense as alcohol, cannabis, opioid, and nicotine use disorders cluster together genetically into one brain disorder